A new study identifies a molecule that acts cooperatively with a well known oncoprotein to drive progression of noninvasive breast cancer to metastatic, life-threatening disease. The research findings, published by Cell Press in the September issue of the journal Cancer Cell, could have a significant impact on therapeutic decisions by facilitating identification of high risk patients.
More...